THE GLP-1 COMPARISON DESKRESEARCHED OCTOBER 2026
Tirz vs Sema
Advertising disclosure: CoreAge Rx is our featured commercial partner and appears first. Placement is promotional; it is not a clinical superiority ranking. How we are funded
Provider documents

WeightCare review

WeightCare publishes several semaglutide and tirzepatide plan lengths. The starting monthly equivalent, refill charge and refund calculation do not necessarily match.

WeightCare markets semaglutide and tirzepatide through monthly and multi-month programs. Its current cards show lower monthly equivalents for longer terms, while the refill FAQ describes a different price for some continuing tirzepatide plans. That makes the next payment a separate comparison from the starter offer.

This review uses WeightCare’s rendered product pages, FAQ, refund policy and terms checked October 15, 2026. We did not purchase medication, verify pharmacy accreditation or test a clinician response. The analysis concerns what the documents establish about cost, care and ending a plan.

Cost and renewal questions for WeightCare review
Editorial cost checklist · Public documents checked October 15, 2026
OUR TAKE

The plan length, refill price and timing of the medical questionnaire matter as much as the advertised monthly equivalent. Confirm the full payment, dose-specific renewal and cancellation confirmation before enrollment.

Semaglutide monthly option
$399 advertised
Tirzepatide monthly option
$499 advertised
Lower equivalents
Tied to longer program terms
Refill sequence
FAQ: charge, then medical questionnaire
Refund boundary
Questionnaire submission, with stated exceptions

Compare the term attached to each displayed amount

The semaglutide page displays $399 for a monthly option and equivalents of $249, $215 and $139 for three-, six- and twelve-month options. The tirzepatide page displays $499 monthly, with $299, $275 and $216 equivalents for the longer terms. A low equivalent is not proof that the complete program is paid one month at a time at that rate.[source]

Confirm the full amount charged, number of weeks supplied, dose range and financing conditions. The product pages also advertise installment payments; a financing payment is not the total price of care. We have not treated a plan-length headline as a quote for every starting dose, refill or patient.[source]

A starter program and a refill can have different prices

The FAQ describes a seven-day notice before a renewal and says the refill medical questionnaire is sent after the renewal charge is processed. It lists a $499 monthly tirzepatide renewal and a $997 three-month renewal, with separate higher-dose options at $1,350 for three months and $2,150 for six. These figures should not be collapsed into the three-month starter headline.[source]

Ask which renewal applies to the planned treatment, how a clinical change affects the charge and when an adjustment must be requested. Because the clinical check-in follows processing in the described sequence, a patient should clarify the upcoming order before the payment date rather than assuming that completing a later questionnaire is what authorizes the charge.

Company claims describe a pathway, not an independent audit

The terms identify Weightless Medical LLC. WeightCare advertises physician evaluation, ongoing messaging, check-ins and pharmacy delivery. It describes pharmacies as accredited, but the public pages reviewed do not identify the pharmacy and accreditation for a specific new order. Obtain the clinician and pharmacy details directly.[source]

The FAQ lists exclusions of Alaska, Hawaii, Louisiana and Mississippi for the specified monthly and three-month standard weight-loss plans, while other product categories have different lists. Confirm the exact product and location before paying; do not generalize a microdose or supplement availability list to standard semaglutide or tirzepatide care.

HSA/FSA language does not establish insurance coverage or reimbursement for every patient. Ask about the complete self-pay price and what documentation is provided. The response and delivery claims on the site were not measured for this review.

Keep the compounded-product and outcome limits visible

WeightCare’s public program information describes compounded semaglutide and tirzepatide. A compounded preparation is not an FDA-approved finished drug, and the FDA does not review it for safety, effectiveness or quality before marketing. Confirm the exact formulation and why it is being proposed rather than assuming branded-product trial data establish its performance.[source][source]

The homepage uses ratings, member counts and selected weight-loss stories. We have not audited those claims or their denominators, follow-up periods and missing data. A patient testimonial is not a comparison trial, and a provider’s program should not be ranked against another by borrowing the average result for a different medicine or study population.

The questionnaire is a financial milestone

The refund policy offers a full refund when the assigned physician finds the patient ineligible for a prescription, or when a refund is requested before the medical questionnaire is submitted. After submission, refunds are generally unavailable, though the policy says requests are considered. The ineligibility exception should not be mistaken for a general guarantee after every submitted intake.[source]

Canceling stops future charges but does not itself refund the current period or stop a shipment already paid for. The policy says the program continues through the paid period and billed time is not prorated. For an approved refund after partial shipment of a multi-month plan, medication already received is valued at the regular price of the matching package and dose as of the original purchase date.

That means an unused balance is not necessarily calculated at the original discounted monthly equivalent. Medication returns are not accepted. Approved refunds usually post in five to ten business days according to the policy; we did not verify processing performance. Ask for an example using the specific plan before prepaying.

Get confirmation that the future charge has stopped

The FAQ instructs patients to email support with CANCEL in the subject and says an agent will confirm cancellation. The refund policy also describes cancellation in the account. Refund requests have a separate published contact and phone number. Use the current instructions, retain the confirmation and ask whether any paid order remains scheduled.[source]

The purchasing record should identify the initial and refill prices, actual renewal date, questionnaire stage, medical contact and refund calculation. Those details make a more defensible comparison than a star rating or a low introductory equivalent. The linked guide separates these provider terms from evidence about the medicines themselves.

Your questions, answered

Does canceling automatically refund an order?

No. The policy distinguishes future charges from current paid services and shipments. A refund requires its own eligibility assessment.

Why can the refill price differ from the starter price?

WeightCare lists different renewal and dose-specific packages. Confirm the amount and notice for the selected continuing plan.

THE RESEARCH

Sources & further reading

Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Each source has its own last-checked date below.

  1. WeightCare: current program overviewCurrent primary-source provider document; commercial statements have not been independently validated. · Checked October 15, 2026
  2. WeightCare: rendered semaglutide plan pricesCurrent primary-source provider document; commercial statements have not been independently validated. · Checked October 15, 2026
  3. WeightCare: rendered tirzepatide plan pricesCurrent primary-source provider document; commercial statements have not been independently validated. · Checked October 15, 2026
  4. WeightCare: renewal sequence, eligibility and support FAQCurrent primary-source provider document; commercial statements have not been independently validated. · Checked October 15, 2026
  5. WeightCare: refund policy and partial-shipment calculationCurrent primary-source provider document; commercial statements have not been independently validated. · Checked October 15, 2026
  6. WeightCare: platform terms and Weightless Medical LLCCurrent primary-source provider document; commercial statements have not been independently validated. · Checked October 15, 2026
  7. FDA: compounding and approval questionsFDA explanation: compounded medicines are not FDA-approved. · Checked October 15, 2026

Keep reading